Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection

Yongwen Chen1, Shengxi Wu, Guoning Guo

  • 1Institute of Immunology, PLA, Third Military Medical University, Chongqing, P. R. China.

Plos Pathogens
|July 14, 2011
PubMed

Insights

Programmed death-1 (PD-1) signaling limits liver damage in fulminant viral hepatitis (FH). PD-1 deficiency increases fibrinogen-like protein 2 (FGL2) via IFN-γ and TNF-α, worsening FH. Manipulating PD-1 may treat FH.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Programmed death-1 (PD-1) is crucial for peripheral tolerance and limiting immune-mediated damage.
  • Its role in fulminant viral hepatitis (FH) pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the functional mechanisms of PD-1 in FH induced by murine hepatitis virus strain-3 (MHV-3).
  • To elucidate the role of PD-1 signaling in regulating immunopathological damage during MHV-3 infection.

Main Methods:

  • Analysis of PD-1 expression on immune cells in various tissues post-MHV-3 infection.
  • Comparison of FH severity and fibrinogen-like protein 2 (FGL2) expression in PD-1-deficient and wild-type mice.
  • Assessment of IFN-γ and TNF-α mRNA levels and the effect of their blockade on FGL2 expression and FH pathology.

Main Results:

  • High PD-1 expression was observed on CD4(+), CD8(+) T cells, NK cells, and macrophages in infected tissues.
  • PD-1-deficient mice showed significantly elevated FGL2 expression, leading to more severe liver damage and higher mortality.
  • FGL2 upregulation in PD-1-deficient mice was mediated by increased IFN-γ and TNF-α, and blocking these cytokines attenuated FH pathology.

Conclusions:

  • PD-1 signaling plays a critical role in mitigating immunopathological damage during MHV-3-induced FH.
  • The protective effect of PD-1 involves suppressing IFN-γ and TNF-α, thereby limiting FGL2-mediated liver injury.
  • Targeting PD-1 signaling represents a potential therapeutic strategy for FH immunotherapy.

Related Concept Videos